Singapore: Chinese biotechnology firm, 3SBio, has signed an exclusive license with Korean firm, DiNonA for the develop...
Singapore: Soon, a simple breath test will detect whether a person is infected with a drug resistant tuberculosis strain...
Singapore: Breast cancer therapeutics pipeline has higher innovation in first-in-class molecules, with many new technolo...
Singapore: AbbVie, a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott, h...
Singapore: Australian scientists have developed a new test that can detect bird flu mutation by distinguishing between b...
Singapore: WHO, in consultation with over 70 experts, is assessing the status of two Ebola vaccine candidates for their ...
Singapore: Global biopharmaceutical firm, Roche, is all set to acquire Santaris Pharma, a Denmark based biopharmaceutica...
Singapore: China-based Beike Biotechnology has recieved Chinese Food and Drug Administration (CFDA) nod for filing the a...
Singapore: Danish firm, Mirrx Therapeutics and Australia's Centenary Institute of Cancer Medicine and Cell Biology has f...
Singapore: From September 29-30, 2014, WHO organized an expert consultation to assess the groundwork of ebola vaccine de...
Singapore: Boehringer Ingelheim plans to establish a new large-scale biopharmaceutical production facility for active in...
Singapore: Guangdong subsidiary of China Cord Blood Corporation, a provider of cord blood collection, laboratory testing...
Singapore: Asthma treatment market value will grow from approximately USD15.9 billion in 2013, across eight major countr...
Singapore: A study led by the National University of Singapore (NUS) has found that attaching chemotherapy drug Epirubic...
Singapore: India-based Zydus Cadila has launched the biosimilar of Adalimumab, indicated for the treatment of auto immun...
Singapore: China Biologic Products, China-based biopharmaceutical company, has received China Food and Drug Administrati...
Singapore: Researchers at the National Institute of Health (NIH) have found that immune responses instigated by MERS inf...
Singapore: Under the terms of the agreement, Sanofi will have access to Boehringer Ingelheim's capabilities in Biberach ...
